{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T05:47:00Z","timestamp":1782366420795,"version":"3.54.5"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11302-026-10170-6","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T05:40:12Z","timestamp":1781329212000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A tale of two ATPs: biased activation of the P2X3 receptor"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5171-9394","authenticated-orcid":false,"given":"Paul-Pierre","family":"Boutet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"issue":"50","key":"10170_CR1","doi-asserted-by":"publisher","first-page":"e2504688122","DOI":"10.1073\/pnas.2504688122","volume":"122","author":"J Wang","year":"2025","unstructured":"Wang J et al (2025) Endogenous forms of ATP\u2013ATP4\u2212 and MgATP2\u2212\u2014orchestrate distinct pathophysiological signaling via biased activation of P2X3 receptors. Proc Natl Acad Sci 122(50):e2504688122. https:\/\/doi.org\/10.1073\/pnas.2504688122","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"10170_CR2","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1111\/j.1749-6632.1999.tb11351.x","volume":"868","author":"AB Mackenzie","year":"1999","unstructured":"Mackenzie AB, Surprenant A, North AB (1999) Functional and molecular diversity of purinergic ion channel receptors. Ann N Y Acad Sci 868(1):716\u2013729. https:\/\/doi.org\/10.1111\/j.1749-6632.1999.tb11351.x","journal-title":"Ann N Y Acad Sci"},{"issue":"6497","key":"10170_CR3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/371516a0","volume":"371","author":"S Valera","year":"1994","unstructured":"Valera S et al (1994) A new class of ligand-gated ion channel defined by P2X receptor for extracellular ATP. Nature 371(6497):516\u2013519. https:\/\/doi.org\/10.1038\/371516a0","journal-title":"Nature"},{"issue":"6497","key":"10170_CR4","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/371519a0","volume":"371","author":"AJ Brake","year":"1994","unstructured":"Brake AJ, Wagenbach MJ, Julius D (1994) New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature 371(6497):519\u2013523. https:\/\/doi.org\/10.1038\/371519a0","journal-title":"Nature"},{"key":"10170_CR5","doi-asserted-by":"publisher","unstructured":"Mansoor SE (2022) How structural biology has directly impacted our understanding of P2X receptor function and gating. In: Nicke A (ed) The P2X7 receptor. Methods in Molecular Biology, vol 2510. Springer US, New York, NY, pp 1\u201329. https:\/\/doi.org\/10.1007\/978-1-0716-2384-8_1","DOI":"10.1007\/978-1-0716-2384-8_1"},{"issue":"8","key":"10170_CR6","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1023\/A:1012344803672","volume":"26","author":"YuV Pankratov","year":"2001","unstructured":"Pankratov YuV, Lalo UV, Dashkin AN, Krishtal OA (2001) Heterogeneity of the Functional Expression of P2X3 and P2X2\/3 Receptors in the Primary Nociceptive Neurons of Rat. Neurochem Res 26(8):993\u20131000. https:\/\/doi.org\/10.1023\/A:1012344803672","journal-title":"Neurochem Res"},{"issue":"1","key":"10170_CR7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.autneu.2010.06.002","volume":"158","author":"F Wan","year":"2010","unstructured":"Wan F et al (2010) P2X2\/3 receptor activity of rat nodose ganglion neurons contributing to myocardial ischemic nociceptive signaling. Auton Neurosci 158(1):58\u201364. https:\/\/doi.org\/10.1016\/j.autneu.2010.06.002","journal-title":"Auton Neurosci"},{"issue":"6807","key":"10170_CR8","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/35039526","volume":"407","author":"V Souslova","year":"2000","unstructured":"Souslova V et al (2000) Warm-coding deficits and aberrant inflammatory pain in mice lacking P2X3 receptors. Nature 407(6807):1015\u20131017. https:\/\/doi.org\/10.1038\/35039526","journal-title":"Nature"},{"issue":"6","key":"10170_CR9","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s40265-022-01700-8","volume":"82","author":"A Markham","year":"2022","unstructured":"Markham A (2022) Gefapixant: first approval. Drugs 82(6):691\u2013695. https:\/\/doi.org\/10.1007\/s40265-022-01700-8","journal-title":"Drugs"},{"issue":"9974","key":"10170_CR10","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/S0140-6736(14)61255-1","volume":"385","author":"R Abdulqawi","year":"2015","unstructured":"Abdulqawi R et al (2015) P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study. Lancet 385(9974):1198\u20131205. https:\/\/doi.org\/10.1016\/S0140-6736(14)61255-1","journal-title":"Lancet"},{"issue":"36","key":"10170_CR11","doi-asserted-by":"publisher","first-page":"E3455","DOI":"10.1073\/pnas.1308088110","volume":"110","author":"M Li","year":"2013","unstructured":"Li M, Silberberg SD, Swartz KJ (2013) Subtype-specific control of P2X receptor channel signaling by ATP and Mg2+. Proc Natl Acad Sci 110(36):E3455\u2013E3463. https:\/\/doi.org\/10.1073\/pnas.1308088110","journal-title":"Proc Natl Acad Sci"},{"issue":"37","key":"10170_CR12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2417753122","volume":"122","author":"FG Westermann","year":"2025","unstructured":"Westermann FG, Oken AC, Granith PKE, Marimuthu P, M\u00fcller CE, Mansoor SE (2025) Subtype-specific structural features of the hearing loss\u2013associated human P2X2 receptor. Proc Natl Acad Sci U S A 122(37):e2417753122. https:\/\/doi.org\/10.1073\/pnas.2417753122","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10170_CR13","doi-asserted-by":"publisher","unstructured":"Li M et al (2019) Molecular mechanisms of human P2X3 receptor channel activation and modulation by divalent cation bound ATP. eLife 8:e47060. https:\/\/doi.org\/10.7554\/eLife.47060","DOI":"10.7554\/eLife.47060"},{"issue":"7623","key":"10170_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/nature19367","volume":"538","author":"SE Mansoor","year":"2016","unstructured":"Mansoor SE, L\u00fc W, Oosterheert W, Shekhar M, Tajkhorshid E, Gouaux E (2016) X-ray structures define human P2X(3) receptor gating cycle and antagonist action. Nature 538(7623):66\u201371. https:\/\/doi.org\/10.1038\/nature19367","journal-title":"Nature"},{"issue":"7397","key":"10170_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature11010","volume":"485","author":"M Hattori","year":"2012","unstructured":"Hattori M, Gouaux E (2012) Molecular mechanism of ATP binding and ion channel activation in P2X receptors. Nature 485(7397):207\u2013212. https:\/\/doi.org\/10.1038\/nature11010","journal-title":"Nature"},{"issue":"1","key":"10170_CR16","doi-asserted-by":"publisher","first-page":"7652","DOI":"10.1038\/s41467-024-51815-7","volume":"15","author":"Y-Y Lin","year":"2024","unstructured":"Lin Y-Y et al (2024) Finely ordered intracellular domain harbors an allosteric site to modulate physiopathological function of P2X3 receptors. Nat Commun 15(1):7652. https:\/\/doi.org\/10.1038\/s41467-024-51815-7","journal-title":"Nat Commun"},{"issue":"10","key":"10170_CR17","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41580-018-0049-3","volume":"19","author":"D Wootten","year":"2018","unstructured":"Wootten D, Christopoulos A, Marti-Solano M, Babu MM, Sexton PM (2018) Mechanisms of signalling and biased agonism in G protein-coupled receptors. Nat Rev Mol Cell Biol 19(10):638\u2013653. https:\/\/doi.org\/10.1038\/s41580-018-0049-3","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"10170_CR18","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1111\/j.1476-5381.2010.00796.x","volume":"160","author":"JR Gever","year":"2010","unstructured":"Gever JR et al (2010) AF-353, a novel, potent and orally bioavailable P2X3\/P2X2\/3 receptor antagonist. Br J Pharmacol 160(6):1387\u20131398. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00796.x","journal-title":"Br J Pharmacol"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-026-10170-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-026-10170-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-026-10170-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T05:05:20Z","timestamp":1782363920000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11302-026-10170-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10170"],"URL":"https:\/\/doi.org\/10.1007\/s11302-026-10170-6","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"1 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standard"}},{"value":"This article does not contain any studies with human participants or animals performed by the author.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"58"}}